Severe cryptosporidiosis in a seven-year-old renal transplant recipient - Case report and review of the literature

Pediatric Transplantation

Volumn 11, Issue 1, 2007, Pages 94-100

  Hong, David K ^a   Wong, Cynthia J ^a   Gutierrez, Kathleen ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Azithromycin; Cryptosporidium; Gastroenteritis; Nitazoxanide; Paromomycin; Renal transplant

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; AZITHROMYCIN; BICARBONATE; GABAPENTIN; GLUTAMINE; HUMAN IMMUNOGLOBULIN; LISINOPRIL; METHYLPHENIDATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITAZOXANIDE; PAROMOMYCIN; PREDNISONE; TACROLIMUS; TOPIRAMATE;

ABDOMINAL PAIN; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DEHYDRATION; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FECES; FOLLOW UP; GLOMERULOPATHY; GRAFT RECIPIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; LABORATORY TEST; MALE; NAUSEA; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PROTEINURIA; RECURRENT DISEASE; SCHOOL CHILD; SEIZURE; TACHYCARDIA; VOMITING;

ANIMALS; CHILD; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 33846190187     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00593.x     Document Type: Article

References (47)

1. CHEN XM, KEITHLY JS, PAYA CV, LARUSSO NF. Cryptosporidiosis. N Engl J Med 2002: 346: 1723-1731.
2. FLYNN PM. Cryptosporidium parvum. In: LONG SS, PICKERING LK, PROBER CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2nd edn. Philadelphia: Churchill Livingstone, 2003; pp. 1267-1269.
3. UDGIRI N, MINZ M, KASHYAP R, et al. Intestinal cryptosporidiasis in living related renal transplant recipients. Transplant Proc 2004: 36: 2128-2129.
4. ZARDI EM, PICARDI A, AFELTRA A. Treatment of cryptosporidiosis in immunocompromised hosts. Chemotherapy 2005: 51: 193-196.
5. GUERRANT RL. Cryptosporidiosis: An emerging, highly infectious threat. Emerg Infect Dis 1997: 3: 51-57.
6. MAC KENZIE WR, HOXIE NJ, PROCTOR ME, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994: 331: 161-167.
7. CACCIO S, PINTER E, FANTINI R, MEZZAROMA I, POZIO E. Human infection with Cryptosporidium felis: Case report and literature review. Emerg Infect Dis 2002: 8: 85-86.
8. MEINHARDT PL, CASEMORE DP, MILLER KB. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev 1996: 18: 118-136.
9. TZIPORI S, WIDMER G. The biology of Cryptosporidium. Contrib Microbiol 2000: 6: 1-32.
10. THEODOS CM. Innate and cell-mediated immune responses to Cryptosporidium parvum. Adv Parasitol 1998: 40: 87-119.
11. UNGAR BL, KAO TC, BURRIS JA, FINKELMAN FD. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol 1991: 147: 1014-1022.
12. FROST FJ, TOLLESTRUP K, CRAUN GF, FAIRLEY CK, SINCLAIR MI, KUNDE TR. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals. J Infect Dis 2005: 192: 618-621.
13. BLANSHARD C, JACKSON AM, SHANSON DC, FRANCIS N, GAZZARD BG. Cryptosporidiosis in HIV-seropositive patients. Q J Med 1992: 85: 813-823.
14. VAKIL NB, SCHWARTZ SM, BUGGY BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996: 334: 19-23.
15. MANABE YC, CLARK DP, MOORE RD, et al. Cryptosporidiosis in patients with AIDS: Correlates of disease and survival. Clin Infect Dis 1998: 27: 536-542.
16. COLFORD JM JR, TAGER IB, HIROZAWA AM, LEMP GF, ARAGON T, PETERSEN C. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival. Am J Epidemiol 1996: 144: 807-816.
17. MIAO YM, AWAD-EL-KARIEM FM, FRANZEN C, et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000: 25: 124-129.
18. CURRENT WL, GARCIA LS. Cryptosporidiosis. Clin Microbiol Rev 1991: 4: 325-358.
19. LEWTHWAITE P, GILL GV, HART CA, BEECHING NJ. Gastrointestinal parasites in the immunocompromised. Curr Opin Infect Dis 2005: 18: 427-435.
20. GARCIA LS, BREWER TC, BRUCKNER DA. Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies. J Clin Microbiol 1987: 25: 119-121.
21. CHIEFFI PP, SENS YA, PASCHOALOTTI MA, MIORIN LA, SILVA HG, JABUR P. Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis. Rev Soc Bras Med Trop 1998: 31: 333-337.
22. CLIFFORD CP, CROOK DW, CONLON CP, FRAISE AP, DAY DG, PETO TE. Impact of waterborne outbreak of cryptosporidiosis on AIDS and renal transplant patients. Lancet 1990: 335: 1455-1456.
23. RONCORONI AJ, GOMEZ MA, MERA J, CAGNONI P, MICHEL MD. Cryptosporidium infection in renal transplant patients. J Infect Dis 1989: 160: 559.
24. TRAN MQ, GOHH RY, MORRISSEY PE, et al. Cryptosporidium infection in renal transplant patients. Clin Nephrol 2005: 63: 305-309.
25. ABDO A, KLASSEN J, URBANSKI S, RABER E, SWAIN MG. Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol 2003: 38: 688-691.
26. OK UZ, CIRIT M, UNER A, et al. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron 1997: 75: 171-174.
27. CAMPOS M, JOUZDANI E, SEMPOUX C, et al. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr 2000: 159: 113-115.
28. DELIS SG, TECTOR J, KATO T, et al. Diagnosis and treatment of Cryptosporidium infection in intestinal transplant recipients. Transplant Proc 2002: 34: 951-952.
29. GERBER DA, GREEN M, JAFFE R, GREENBERG D, MAZARIEGOS G, REYES J. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000: 4: 50-55.
30. POZIO E, RIVASI F, CACCIO SM. Infection with Cryptosporidium hominis and reinfection with Cryptosporidium parvum in a transplanted ileum. APMIS 2004: 112: 309-313.
31. HEWITT RG, YIANNOUTSOS CT, HIGGS ES, et al. Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis 2000: 31: 1084-1092.
32. WHITE AC JR, CHAPPELL CL, HAYAT CS, KIMBALL KT, FLANIGAN TP, GOODGAME RW. Paromomycin for cryptosporidiosis in AIDS: A prospective, double-blind trial. J Infect Dis 1994: 170: 419-424.
33. SMITH NH, CRON S, VALDEZ LM, CHAPPELL CL, WHITE AC Jr. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis 1998: 178: 900-903.
34. REHG JE. A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. J Infect Dis 1994: 170: 934-938.
35. RAPP RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: Enhanced tissue activity and minimal drug interactions. Ann Pharmacother 1998: 32: 785-793.
36. AMACHER DE, SCHOMAKER SJ, RETSEMA JA. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother 1991: 35: 1186-1190.
37. MORI T, AISA Y, NAKAZATO T, YAMAZAKI R, IKEDA Y, OKAMOTO S. Tacrolimus-azithromycin interaction in a recipient of allogeneic bone marrow transplantation. Transpl Int 2005: 18: 757-758.
38. GREENBERG PD, CELLO JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996: 13: 348-354.
39. NORD J, MA P, DIJOHN D, TZIPORI S, TACKET CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990: 4: 581-584.
40. BOROWITZ SM, SAULSBURY FT. Treatment of chronic cryptosporidial infection with orally administered human serum immune globulin. J Pediatr 1991: 119: 593-595.
41. KUHLS TL, ORLICEK SL, MOSIER DA, CRAWFORD DL, ABRAMS VL, GREENFIELD RA. Enteral human serum immunoglobulin treatment of cryptosporidiosis in mice with severe combined immunodeficiency. Infect Immun 1995: 63: 3582-3586.
42. PAPE JW, LEVINE E, BEAULIEU ME, MARSHALL F, VERDIER R, JOHNSON WD Jr. Cryptosporidiosis in Haitian children. Am J Trop Med Hyg 1987: 36: 333-337.
43. CRABB JH. Antibody-based immunotherapy of cryptosporidiosis. Adv Parasitol 1998: 40: 121-149.
44. OCHOA TJ, WHITE AC Jr. Nitazoxanide for treatment of intestinal parasites in children. Pediatr Infect Dis J 2005: 24: 641-642.
45. AMADI B, MWIYA M, MUSUKU J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: A randomised controlled trial. Lancet 2002: 360: 1375-1380.
46. ROSSIGNOL JF, HIDALGO H, FEREGRINO M, et al. A double- 'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998: 92: 663-666.
47. BLIKSLAGER A, HUNT E, GUERRANT R, RHOADS M, ARGENZIO R. Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis. Am J Physiol Gastrointest Liver Physiol 2001: 281: G645-G653.